Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies.

Bouthaina Shbib Dabaja, Andrea K Ng, Stephanie A Terezakis, John P Plastaras, Micheal Yunes, Lynn D Wilson, Lena Specht, Joachim Yahalom

February 2020 Int J Radiat Oncol Biol Phys

Synopsis of Social media discussions

The discussions reflect a supportive attitude toward the guidelines, with posts mentioning specific constraints like '5 Gy IDL' and consolidation techniques for larger areas, which illustrate technical engagement. The tone is professional and focused on practical application, emphasizing the importance of standardization and precision in radiation therapy for hematological cancers, thus indicating a moderate but meaningful impact on clinical practices.

A
Agreement
 Moderate agreement

Most discussions support the importance and utility of the guidelines, indicating a general agreement with their value.

I
Interest
 Moderate level of interest

Participants show moderate interest, often referencing specific constraints, methods, or related tools, but the overall tone remains professional and somewhat reserved.

E
Engagement
 Moderate level of engagement

Posts include technical details, such as dimensions for consolidating radiation fields and referencing visual guides, demonstrating active engagement.

I
Impact
 Moderate level of impact

The emphasis on implementing guideline recommendations and referencing supporting tools suggest the discussions recognize a meaningful potential to influence clinical practice.

Social Mentions

YouTube

4 Videos

Twitter

17 Posts

Metrics

Video Views

2,037

Total Likes

71

Extended Reach

45,420

Social Features

21

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Radiation Therapy Strategies for NK/T-Cell Lymphoma Effectiveness and Guidelines

Radiation Therapy Strategies for NK/T-Cell Lymphoma Effectiveness and Guidelines

Dr. Bouthaina Dabaja discusses the use of radiation therapy in managing NK/T-cell lymphoma, emphasizing precise target delineation to optimize treatment outcomes and minimize healthy tissue damage according to established guidelines.

ILROG Team

November 16, 2020

687 views

Radiation Therapy for Lymphoma of the Mesentery Explained

Radiation Therapy for Lymphoma of the Mesentery Explained

Dr. Dabaja discusses radiation therapy's role in treating lymphoma of the mesentery, emphasizing accurate target delineation to improve treatment effectiveness and reduce healthy tissue damage, based on recent guidelines.

ILROG Team

November 16, 2020

516 views

Radiation Therapy Advances in Managing Gastric Lymphoma

Radiation Therapy Advances in Managing Gastric Lymphoma

Bouthaina Dabaja MD discusses the use of radiation therapy in the management of gastric lymphoma, emphasizing precise target delineation guidelines for hematological malignancies to improve treatment effectiveness and minimize healthy tissue damage.

ILROG Team

November 16, 2020

476 views

Radiation Therapy for Head and Neck Lymphoma: Guidelines and Techniques

Radiation Therapy for Head and Neck Lymphoma: Guidelines and Techniques

Dr. Dabaja discusses how radiation therapy is used to treat lymphoma in the head and neck, emphasizing the importance of precise target delineation to improve treatment effectiveness and reduce harm to healthy tissue.

ILROG Team

November 16, 2020

359 views

  • Jeff Ryckman
    @jryckman3 (Twitter)

    @drbeckta @NicholasZaorsky @CunninghamOnc @JillGunther @ILROGTeam Hah! Glad you asked. Peds and heme are the only scenarios where I care about 5 Gy IDL. Easy heme constraints:
    view full post

    May 2, 2022

    7

  • Uzoma K. Iheagwara, MD, PhD
    @UzomaMDPhD (Twitter)

    RT @jryckman3: @SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high ri…
    view full post

    March 12, 2022

    2

  • David Russler-Germain, MD/PhD
    @dgermain21 (Twitter)

    RT @jryckman3: @SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high ri…
    view full post

    March 11, 2022

    2

  • Jeff Ryckman
    @jryckman3 (Twitter)

    @SanghviMd @AaronGoodman33 Nailed it! Also, I tend to consolidate if >5 cm in any direction, CT-based resid >2cm, or high risk for complications from LR (e.g., cord/SRE). Of course, keep 5-15 Gy IDL out of OARs. Modern techniques, ftw!
    view full post

    March 11, 2022

    6

    2

  • Jeff Ryckman
    @jryckman3 (Twitter)

    @_katelynatkins @avirupguha @HinaSaeedMD @AmishiBajajMD @Rad_Nation @subatomicdoc @BreastDocUK @IanJPereira @MonaArbabMD @ChaurasiaMD @NorthwesternMed @Dr_RayMak @KathrynBanfill Here are NCCN gastric constraints - seem to hover around 30 Gy. For MALT, could likely invoke ILROG recs to keep 5 Gy IDL out of surrounding organs at risk - including ❤️. #ALARA #radonc #jc T4 - but for other malignancies
    view full post

    April 18, 2021

    5

  • Sara Navarro MD, MSc
    @sakenaes (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    April 24, 2020

    9

  • Castalia Fernández, MD.
    @FuenteApolo (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    April 24, 2020

    9

  • eContour
    @eContourRadOnc (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    April 21, 2020

    9

  • ARRO
    @ARRO_org (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    February 12, 2020

    9

  • Percy Lee MD
    @PercyLeeMD (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    February 12, 2020

    9

  • Oncologylondon
    @oncologylondon (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    February 10, 2020

    9

  • Joaquín J Cabrera. PhD.
    @JoaquinJCabrera (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    February 10, 2020

    9

  • ILROG Team
    @ILROGTeam (Twitter)

    RT @BouthainaDabaja: @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part…
    view full post

    February 9, 2020

    9

  • Bouthaina Dabaja MD
    @BouthainaDabaja (Twitter)

    @ILROGTeam @ASTRO_org @ASH_hematology @ASCO @LLSusa @lymphoma @MDAndersonNews download the easy visual mini-atlas part I for @ASH_hematology radiation fields guide, part II coming soon!!!.t https://t.co/fGmc4Ze8UY. @ASTRO_org @MDAndersonNews @ASCO @ARRO_org @TaniguchiMD @lymphoma @LLSusa @Lymphoma_Papers https://t.co/JvwRPKwDdE
    view full post

    February 7, 2020

    19

    9

  • Christian Flores MD MPH
    @ChrisFloresRT (Twitter)

    Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies - ScienceDirect https://t.co/EV79TyZ0EI
    view full post

    January 24, 2020

    2

  • Adela
    @adelapoite (Twitter)

    Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies https://t.co/GaOYW7wgf4
    view full post

    January 9, 2020

  • Med Phys Papers
    @medphyspapers (Twitter)

    IJROBP: "Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies" https://t.co/sjQXB0s4ri
    view full post

    January 9, 2020

Abstract Synopsis

  • The document focuses on guidelines for accurately defining radiation therapy target areas in patients with hematological cancers to improve treatment effectiveness.
  • It emphasizes the importance of careful delineation of every gray zone, or uncertain area, to ensure precise radiation delivery and minimize damage to healthy tissue.
  • The guidelines aim to standardize practices across different sites to enhance consistency and outcomes in radiation therapy for hematological malignancies.]